Goodwin Procter and Kromann Reumert are advising Novo Holdings on the transaction, Skadden, Arps, Slate, Meagher & Flom is advising Catalent, Inc. and Jones Day is...
Novo Holdings’ Acquisition of Catalent
Doctor Anywhere’s Series C1 Financing
Allen & Gledhill advised Square Peg and Novo Holdings on the deal. Square Peg and Novo Holdings led the US$40.8 million series C1 extension all- equity...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Cinven’s Acquisition of SYNLAB AG
On the transaction, Clifford Chance has acted for Ephios Luxembourg; Kirkland & Ellis has advised Cinven; Latham & Watkins has advised Novo Holdings A/S The Fifth...
Avalyn Pharma’s $175 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings A/S and Vida Ventures on the transaction. Avalyn Pharma Inc. announced the closing of an oversubscribed $175 million...
Novo Holdings and Industriens Pension’s Joint Venture Agreement with NREP and DSB to Develop The Railway District (Jernbanebyen) in Copenhagen
Plesner advised Novo Holdings and Industriens Pension on the deal. Novo Holdings and Industriens Pension signed agreements to ensure a joint long-term partnership where NREP is engaged...
Metagenomi’s $100 Million Series B Extension Financing
Wilson Sonsini Goodrich & Rosati advised Novo Holdings and Metagenomi on the deal. Fenwick represented Metagenomi. Gene editing company Metagenomi announced a $100 million Series B...
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
Novozymes’ $12.3 Billion Merger with Chr. Hansen
Simpson Thacher represented Gordon Dyal & Co. in the transaction, while Davis Polk and Plesner advised Novozymes. Kromann Reumert has advised Novo Holdings and the Novo...
Roslin Tech’s £11 Million Series A Funding Round
Goodwin Procter advised Novo Holdings on the deal. Novo Holdings acted as a lead investor in Roslin Tech’s £11 million Series A funding round. Other participating...
Medanta’s RS 500 Crore Initial Public Offering
Luthra and Luthra Law Offices India has represented Novo Holdings in a pre-IPO deal involving secondary purchase of shares of Global Health Limited from Anant Investments,...
Novo Holdings’ Acquisition of KabaFusion
Goodwin Procter advised Novo Holdings on the deal. Novo Holdings announced its acquisition of KabaFusion from Pritzker Private Capital. Novo Holdings is a leading international healthcare...